The transmembrane metalloproteases angiotensin-converting enzyme (ACE) and tumor necrosis factor-a (TNF-a)-converting enzyme (TACE/ADAM-17) have been associated with inflammation, cancer progression and angiogenesis. Few investigations into the regulation of these enzymes by physiological stimuli have been reported. In this study, we investigated the influence of interferons (IFNs) type I (a, b) and II (c) on ACE and TACE expression of human leukemic NB4 cells and monocytes.
Introduction
The transmembrane metalloproteases angiotensinconverting enzyme (ACE/CD143) and tumor necrosis factor-a (TNF-a)-converting enzyme (TACE/ADAM-17/CD156) are considered as useful markers in some inflammatory and tumoral diseases (Bauvois, 2004) . Overexpression of ACE is observed in breast, lung and gastric cancer (Bauvois, 2004; Rocken et al., 2005) , whereas TACE increase has been associated with prostate cancer (Bauvois, 2004) . Both enzymes are expressed by a variety of cell types (Bauvois, 2004) . In the immune system, ACE and TACE are mainly found in monocytes (Bauvois, 2004) . Monocytes infiltrating injured tissues (inflammation, tumors) play a crucial role by expressing and/or releasing cytokines, chemokines and proteases (Muller, 2001) . ACE and TACE have been implicated in the control of major biological processes, including growth and secretion of inflammatory and angiogenic cytokines (Bauvois, 2004) . Through its shedding activity, TACE is responsible for the conversion of the TNF-a precursor to TNF-a and for releasing other membrane-bound proteins such as TNFreceptor, amyloid-protein precursor, transforming growth factor-a, vascular cellular adhesion molecule-1 (VCAM-1) and intercellular cell adhesion molecule-1 (ICAM-1), all proteins involved in the onset and/or progression of several diseases (Black et al., 1997; Garton et al., 2003; Bauvois, 2004; Tsakadze et al., 2006) . In animal models, ACE inhibitors have been shown to reduce tumor growth and metastasis and to perturb angiogenesis (Bauvois, 2004; Lindberg et al., 2004; Yoshiji et al., 2004; Deshayes and Nahmias, 2005) .
So far, little is known about the regulation of ACE and TACE by inflammatory and angiogenic cytokines. ACE is induced by vascular endothelial growth factor and basic fibroblast growth factor in human umbilical vein endothelial cells (HUVEC) (Okabe et al., 1987; Saijonmaa et al., 2001b) or downregulated by TNF-a and interleukin (IL)1b in HUVECs (Saijonmaa et al., 2001a) . TNF-a stimulates TACE expression in murine and human endothelial cell lines (Bzowska et al., 2004) . Therefore, increased knowledge of the physiological mechanisms by which ACE and TACE are regulated is of particular interest in view of the comprehension of their roles in diseased conditions. Interferons (IFNs) belong to a family of cytokines that are implicated in anti-viral, anti-proliferative, antitumoral and immunomodulatory effects (Stark et al., 1998; Chawla-Sarkar et al., 2003) . IFNs are negative regulators of angiogenesis (Lindner, 2002; Caceres and Gonzalez, 2003) . The efficacy of IFNs has been exploited in maintenance therapy for patients with various cell diseases, including cancers and leukemias (Guilhot et al., 2004; Borden, 2005; Moschos et al., 2005) . The therapeutic potential of IFNs in association with other cytokines is currently under investigation (Lindner and Borden, 1997; Lindner, 2002; Caceres and Gonzalez, 2003) . Although sharing common biological properties, IFNs type I (a, b) and II (g) activate both similar and dissimilar signaling pathways (Kalvakolanu, 2003; Schroder et al., 2004) .
We investigated whether type I and II IFNs were capable of regulating ACE and TACE in human normal and leukemic monocytic cells. In the present work, we report for the first time that both types of IFNs downregulate TACE through internalization, whereas IFNg upregulates ACE at the transcriptional level in NB4 cells and in monocytes, with the possible participation of interferon-responsive factor 1 (IRF1) in ACE gene activation.
Results
Surface expression of ACE and TACE on human monocytes throughout their in vitro differentiation Monocytes were isolated from blood of healthy donors and used either directly (day 0) or following culture for indicated periods of time (days 1, 2 and 7). As described previously (Kaplan and Gaudernack, 1982) , monocytes developed into macrophages when cultured for 7 days in the presence of serum. The results of reverse transcriptase-polymerase chain reaction (RT-PCR) of ACE, TACE and b2-microglobulin in cultured monocytes are shown in Figure 1a . Day 0-monocytes expressed TACE transcript, whereas no detectable ACE transcript was found. ACE transcript was induced upon monocyte culture accompanied by no marked change in the amounts of TACE mRNA ( Figure 1a ). Figure 1b shows that day 0-monocytes expressed at their surface low levels of ACE, whereas day 7-macrophages displayed an increased ACE signal. Thus, the upregulation of ACE mRNA levels in cultured monocytes appeared correlated with the increased levels of ACE protein. In contrast, high levels of TACE were measured on the surface of monocytes and macrophages ( Figure 1b ).
Divergent regulation of surface ACE and TACE by IFNs in leukemic NB4 cells
To investigate the potential effects of IFNs on ACE and TACE expression in monocytic cells, we chose the leukemic myeloid NB4 cell line, which expresses, like monocytes, intermediate and high levels of ACE and TACE, respectively (Figure 2a ). The culture of NB4 cells for 3 days in the presence of IFNs a, b or g (1000 U/ ml) led to a decrease in surface TACE density (Figure 2a ). In contrast, IFNg, but not type I IFNs, markedly increased the percentage of ACE-positive cells as well as surface ACE density (Figure 2a ). To determine if these different regulations were related to alterations in the levels of ACE and TACE mRNA, RT-PCR analysis was performed (Figure 2b ). The ACE message found in unstimulated NB4 cells was not affected by IFNa/b treatment whereas stimulation with IFNg led to a marked increase in ACE mRNA product (Figure 2b , fivefold increase). This suggested that IFNgmediated enhancement of ACE protein was the result of upregulated ACE mRNA levels. In contrast, there was no apparent change in mRNA contents of TACE upon stimulation with all IFNs (Figure 2b ), suggesting a posttranscriptional downregulation. IFNs affect ACE and TACE in normal and leukemic myeloid cells D Obeid et al maximal effects of IFNg being obtained for doses at 1000 U/ml ( Figure 3a ) and time-dependent with maximal effects being already obtained at day 1 (Figure 3b ). Similar inhibitory dose-and time-dependent effects of IFNa/b on TACE expression were observed (data not shown). In contrast, the stimulatory effect of IFNg on the expression of surface ACE was optimal at 1000 U/ml ( Figure 3a) and increased with time, indicating a rapid and long-lasting process (Figure 3b ).
IFNg induces TACE internalization in NB4 cells
Soluble form of TACE exists in biological fluids (Bauvois, 2004) . Whether downregulation of TACE by IFNs was accompanied by the concomitant release of soluble TACE was assessed by enzyme-linked immunosorbent assay (ELISA) in the conditioned media of IFNtreated NB4 cells. However, no detectable levels of soluble TACE were found (data not shown), suggesting no TACE release. We next investigated the nature of the decrease of surface TACE by IFNg. NB4 cells were incubated with IFNg (1000 U/ml) for 24 h before extensive washing and further 2 days of incubation in the culture medium. Inhibition of surface TACE was lost upon cell washing ( Figure 4A ), indicating the reversible nature of IFN-mediated inhibition.
Whether IFNg could cause TACE internalization was subsequently studied. Flow cytometry showed that TACE expression in permeabilized NB4 cells was increased following 24 h of culture with IFNg when compared with control cells ( Figure 4B ). We then examined by immunofluorescence microscopy the localization of TACE and the effect of IFNg on the distribution of TACE in permeabilized NB4 cells ( Figure 4C ). In untreated NB4 cells, most of TACE was associated with the plasma membrane ( Figure 4Cc ) whereas in IFNg-treated cells, TACE was mostly /ml) cultured in the absence or presence of IFNs (1000 U/ml) were used as templates for PCR reactions using specific primers for ACE, TACE and b2-microglobulin. PCR products were run on 2% agarose gels. /ml) were cultured in the absence or presence of increasing concentrations of IFNg (10-1000 U/ml) for 3 days. Results are expressed as ACE and TACE relative density (three independent experiments7s.e.m.). *P o0.05 vs control. (b) NB4 cells (1 Â 10 5 /ml) were cultured in the absence or presence of 1000 U/ml IFNg for 18, 24, 48 and 72 h. Results are expressed as ACE and TACE relative density (three independent experiments7s.e.m.). *Po0.05 vs control. Relative density was expressed as ACE or TACE density value of IFN-stimulated cells relative to ACE or TACE density value of unstimulated cells.
IFNs affect ACE and TACE in normal and leukemic myeloid cells D Obeid et al expressed in the cytoplasm ( Figure 4Cd ). Together, these data strongly suggest that IFNg-mediated downregulation of surface TACE resulted in an accumulation of intracellular TACE.
ACE protein upregulation by IFNg is correlated with increase in ACE activity
Whether ACE upregulation by IFNg was associated with enhanced ACE enzymatic activity was assessed by measuring the rate of hydrolysis of the chromogenic substrate N-(3-[2-furyl]acryloyl)-phenylalanyl-glycylglycine (FAPGG). Specificity of substrate hydrolysis was confirmed by inhibition of ACE activity (X80%) by captopril and enalaprilat, specific ACE inhibitors. As shown in Figure 5a , FAPGG hydrolysis was specifically increased after 24 h of IFN-g treatment and paralleled the enhancement of ACE observed under the same conditions. These data indicate that the augmented level of ACE activity in IFNg-stimulated NB4 cells was associated with the induction of ACE protein.
Cycloheximide treatment prevents upregulation of ACE in IFNg-treated NB4 cells To determine if de novo protein synthesis was required for ACE upregulation by IFNg, NB4 cells were stimulated for various periods of time in the presence or absence of the protein synthesis inhibitor cycloheximide. We first assessed whether this chemical inhibitor was non-toxic in the range of concentration tested (1-50 mM) and optimal non-cytotoxic concentration of 10 mM was determined in initial experiments. As shown in Figure 5b , cycloheximide itself exerted a slight effect on the surface expression of ACE starting 18 h. When combined with IFNg, cycloheximide totally prevented the increase of ACE mediated by IFNg at 18 and 24 h (Figure 5b ). This suggested that de novo synthesized proteins induced in response to IFNg were involved in the regulation of ACE.
Effects of IFNs on ACE and TACE expressed by human monocytes
We thus investigated whether our observations on the divergent effects of IFNs toward ACE and TACE in NB4 cells were validated on normal monocytes. Monocytes are IFN-responsive cells (Le Page et al., 2000) . As shown in Figure 6a , IFNg treatment up to 3 days markedly upregulated surface expression of ACE, whereas IFNs type I were without any significant effect. Parallel RT-PCR analysis showed upregulated levels of ACE mRNA in IFNg-treated cells (Figure 6b ). In contrast, both types of IFNs downregulated surface TACE (the optimal effect being observed with IFNg) (Figure 6a ) without altering TACE transcript (Figure 6b) . These data therefore demonstrate the ability of IFNs to differentially regulate ACE and TACE in monocytes, as previously found for NB4 cells.
Impact of IFNg on surface ACE expression in IRF1 signaling-deficient HepG2 cells IFNs induce the transcription factor IRF1 that acts on some type I-and II-stimulated genes (Kalvakolanu, 2003; Schroder et al., 2004) . As IFNg-dependent stimulation of ACE was abolished by cycloheximide, we assessed if de novo synthesized IRF1 was involved in IFNg-induced expression of ACE. For this purpose, we chose to study ACE expression in the HepG2 epithelial cell line, which has a defective secondary pathway for IRF1 (Tnani and Bayard, 1999) . In these cells, IRF1 is normally induced by IFNs and functional; however, some IFN-induced genes normally expressed as a secondary response to IFNs in various cell types are no longer inducible in HepG2 cells (Tnani and Bayard, 1999) . Indeed, Western blotting studies showed that IFNg treatment induced IRF1 protein in whole lysates from monocytes, NB4 cells as well as HepG2 cells (Figure 6c ). The impact of IFNg (1000 U/ml) on surface ACE expression was further compared in monocytes and NB4 cells with HepG2 cells (Table 1 
Discussion
Our present study has provided first evidence that IFNs are capable of regulating the expression of ACE and TACE of human monocytes and leukemic NB4 cells. Additional experiments showed that other leukemic myeloid cell lines (HL-60, U937, THP-1, MonoMac6) similarly downregulated TACE and upregulated ACE in response to IFNs (data not shown), thus indicating that divergent regulation of ACE and TACE is a general feature of the myeloid lineage cells to IFNs.
We showed that surface ACE protein was upregulated as a likely consequence of increased level of ACE transcript in IFNg-treated monocytic cells. The upregulation of ACE protein by IFNg was associated with functional ACE activity. In contrast, IFNs type I did not exert any significant effect on ACE expression. As IFNg enhances TNF-a release from monocytes (Nguyen et al., 2005) , whether TNF-a through an autocrine loop could influence ACE expression was considered. We found that exogenous TNF-a as well as a neutralizing antibody against TNF-a, in the absence or presence of IFNg, did not affect the levels of surface ACE (data not shown), thus excluding the eventual participation of endogenous TNF-a in the effect produced by IFNg on ACE.
In IFN signaling, activation of the associated tyrosine kinases Janus kinase1 (JAK1)/Janus kinase2 (JAK2) (for IFNg) and JAK1/Tyk-2 (for IFNa and IFNb) leads to phosphorylation and homodimerization of the transcription factor signal transducer and activators of transcription 1a which is then translocated to the Cycloheximide (10 mM) was added to NB4 cells in the absence or presence of IFNg (1000 U/ml) and was present throughout the stimulation periods (6, 18, 24 h). ACE relative density was detected by flow cytometry. Results at 24 h are the mean of two to six independent experiments7s.e.m. *Po0.05 vs control.
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nucleus where it binds IFNg-activated site (GAS) motifs to activate the transcription of various genes including IRF1 gene (Kalvakolanu, 2003; Schroder et al., 2004) . These events do not require new protein synthesis. Here, the IFNg-dependent stimulation of ACE was abolished by cycloheximide, suggesting that de novo synthesized IRF1 was necessary for IFNg-induced expression of ACE. IRF1 binds IFN-stimulated response element (ISRE) sequences that may overlap with IFN-responsive element sequences (Kalvakolanu, 2003; Schroder et al., 2004) . The ACE promoter contains a number of consensus transcription factor binding sites, including Egr-1, Sp1, ets-1 and AP2 (Eyries et al., 2002) . The upregulation of ACE by phorbol 12-myristate-13-acetate (PMA) occurs through the Egr-1 transcription factor (Eyries et al., 2002) . By using the MatInspector software developed by Genomatix (Munich, Germany), we found that ACE promoter possesses one consensus IRF1 binding site (at À1597 to 1615). We thus searched for the possible participation of IRF1 in ACE gene activation. As a model of IRF1-dependent gene expression deficient cell line, we used HepG2 cells in which IRF1 is induced normally and is functional, whereas the secondary pathway involving IRF1, but not IRF1 itself, is defective (Tnani and Bayard, 1999) . The IRF1 secondary response leading to the induction of RNase L, indoleamine 2,3-dioxygenase, inducible NO synthetase and guanylate binding protein-2 genes is impaired in these cells (Tnani and Bayard, 1999 (Nguyen et al., 1997; Taki, 2002) . IRF4 and ICSBP, expressed in lymphocytes and macrophages, are absent in HepG2 cells (Tnani and Bayard, 1999) , whereas IRF2 is expressed in both monocytic and HepG2 cells (Matikainen et al., 1998; Tnani and Bayard, 1999) . Therefore, the potential involvement of these molecules in the repression of IRF1 activity in HepG2 cells appears unlikely. Instead, /ml) were cultured in the absence or presence of of IFNs (1000 U/ml) for 1 and 3 days. Results are expressed as ACE and TACE relative density (two to four independent experiments7s.e.m.); *Po0.05 vs control. (b) Monocytes (1 Â 10 6 cells/ml) were cultured 18 h in the absence or presence of IFNg. PCR analyses were performed on ACE, TACE and b2-microglobulin transcripts. (c) Monocytes, NB4 and HepG2 cells (1 Â 10 6 /ml) were cultured in the absence or presence of IFNg (1000 U/ml) for 18 h. Whole cell lysates (50-100 mg) were separated by 12% sodium dodecyl sulphate-polyacrylamide gel electrophoresis. Western blots were probed with Abs against IRF1 or actin. (40) 62 (9) 56 (79) Abbreviations: ACE, angiotensin-converting enzyme; IFN, interferon. Cells cultured for 1 day or 3 days in the absence or presence of IFNg (1000 U/ml) were assayed for expression of surface ACE. Values are given as % of ACE-positive cells and ACE relative density per cell (in brackets).
IFNs affect ACE and TACE in normal and leukemic myeloid cells D Obeid et al a cycloheximide-sensitive transcription factor lacking in HepG2 cells could be required for a correct expression of defective HepG2 genes (Tnani and Bayard, 1999) . We report that types I and II IFNs caused a decrease in the levels of surface TACE protein of NB4 cells and monocytes with no apparent change in TACE transcripts. A large number of transmembrane proteins can be released from cells by proteolysis (Hooper et al., 1997) . However, unstimulated or IFN-stimulated NB4 cells and monocytes produced no detectable amounts of soluble TACE, suggesting that TACE downregulation was not a consequence of TACE shedding. The downregulation of surface TACE in NB4 cells was reversible and correlated with an increase in intracellular TACE protein in permeabilized cells as measured by fluorescence-activated cell sorter (FACS) and by immunofluorescence microscopy. Thus, the IFN-induced downregulation of surface TACE seemed to likely occur via the internalization of TACE. Previous studies showed that PMA upregulated TACE transcripts in leukemic myeloid tamm-horsefall protein-1 (THP-1) cells (Worley et al., 2003) and downregulated surface TACE (Doedens and Black, 2000) . This downregulation occurred via the internalization and degradation of TACE molecules (Doedens and Black, 2000) . These authors (Doedens and Black, 2000) suggested that PMA-mediated internalization of TACE could occur via clathrin-coated pits as the cytoplasmic domain of TACE contains a potential YXXO internalization motif (YESL, residues 702-705 of human TACE) (Marks et al., 1996) . Similarly, IFNg downregulated TNF and IFN receptors in macrophages and myeloid U937 cells, respectively, via clathrin-coated structures (Ohmann et al., 1990; Sadir et al., 2001) .
IFNs have previously been shown to downregulate the gene expression of matrix metalloproteinase-9 in human monocytes via IRF1 binding competition with nuclear factor-kB Nguyen et al., 2005) and such inhibition accounted for reduced monocyte invasiveness (Nguyen et al., 2005) . We demonstrated here the divergent influence of IFNs on the ACE/TACE balance in human monocytic cells. Whether respective up-and downregulation of ACE and TACE by IFNs confers a selective advantage or disadvantage on human monocytes and tumoral cells infiltrated in diseased tissues remains to be determined. The renin-angiotensin system including the generation of angiotensin II by ACE is important to the control of blood pressure and renal function, and is involved in diabetes, angiogenesis, tumor growth and cardiovascular diseases (Fuchs et al., 2004; Yoshiji et al., 2004) . Therefore, it can be speculated that IFNg by enhancing ACE expression could have a detrimental effect in these processes. TACE is the major sheddase of TNF-a and is essential for the generation of soluble, mature TNF-a (Black, 2002) . TNF-a is a central mediator in inflammatory and tumoral pathologies (stroke, rheumatoid arthritis, cancer) (Newton et al., 2001; Levin, 2004; Lovering and Zhang, 2005) and our data suggest that IFNg by downregulating TACE could have therapeutic potential in treating these diseases.
Materials and methods

Materials
Recombinant human (rh) IFNg (2 Â 10 7 U/mg) and rh TNF-a (4 Â 10 8 U/mg) were supplied by R&D (Abindgton, UK). Rh IFNa2a (2 Â 10 8 U/mg) and rh IFNb (2 Â 10 8 U/mg) were provided by Hoffman-La Roche (Basel, Switzerland) and by Ares-Serono (Geneva, Switzerland), respectively. Cycloheximide, FAPGG and captopril were obtained from Sigma (Saint Louis, MO, USA). Irrelevant mouse (m)IgGs, F(ab 0 )2 fragment anti-mouse fluorescein isothiocyanate-conjugated Ig and monoclonal antibodies (mAbs) (FITC) specific for CD11b (mIgG1, BEAR 1), CD14 (mIgG2a, 134620) and HLA-DR (mIgG1, Immu-357) were obtained from Coulter/ Beckman (Luminy, France). Anti-CD64/Fc-gRI-PE (mIgG1, VI MA36) was from BD Pharmingen (Eiembadegem, Belgium). Unlabeled anti-TACE and anti-TACE-PE (mIgG1, 111633) were obtained from R&D (Adbington, UK). Anti-ACE-FITC (mIgG1, i1A8) was from Abcam (Cambridge, UK). Anti-IRF1 (rabbit polyclonal IgG, C-20) was from Santa Cruz Biotechnology (Tebu, France). Anti-actin (mIgG1, C4) was from ICN Biomedicals (Irvine, CA, USA).
Human cell lines
The myeloblastic NB4 cell line was a gift from Dr Lanotte (Hoˆpital Saint Louis, Paris, France). Cells were maintained in Rosewell Park Memorial Institute (RPMI) 1640 medium supplemented with 5% heat-inactivated fetal calf serum (FCS, Gibco, Parsley, Scotland; LPS levels o0.1 ng/ml), 2 mM L-glutamine, 1 mM sodium pyruvate and 40 mg/ml gentamycin (Flow laboratories, Rockwell, MD, USA) in a 5% CO 2 humidified atmosphere at 371C. The epithelial HepG2 and HEK-293 cell lines were from ATCC. HepG2 cells were maintained in Dulbecco's modified Eagle's medium (DMEM)-F12 medium supplemented with 10% FCS, 2 mM L-glutamine, 1 mM sodium pyruvate and 40 mg/ml gentamycin in a 5% CO 2 humidified atmosphere at 371C. HEK-293 cells were maintained in DMEM supplemented with 10% FCS, 2 mM L-glutamine, 1 mM sodium pyruvate and 40 mg/ml gentamycin in a 5% CO 2 humidified atmosphere at 371C.
Obtention of isolated monocytes
Human peripheral blood monocytes were isolated by FicollHypaque density gradient (1.077 g/ml) centrifugation and adherence as described (Bauvois et al., 1996) (Nguyen et al., 2005) .
Cell stimulation assays
For stimulation assays, cells (1 Â 10 5 /ml for NB4, HepG2 and HEK-293) (1 Â 10 6 /ml for monocytes) were cultured in complete RPMI 1640 medium at 371C in the absence or presence of various concentrations of IFNs (10-1000 U/ml). After various periods of incubation, cells were collected, washed twice, counted with a Coulter Counter ZM equipped with a Coultronic 256 channelizer (Coulter/Beckman) and their viability was determined.
Flow cytometry analysis
Intact cells were immunostained as described (Bauvois et al., 1996) . Intracellular TACE staining was performed in ACE activity assay ACE activity in cell lysates was measured spectrophotometrically by hydrolysis of FAPGG and formation of FAP as described previously (Holmquist et al., 1979; Maguire and Price, 1985; Golikov and Nikolaeva, 1998) . Cells were lysed in protease buffer (100 mM HEPES, pH 8.2, 0.12 M NaCl, 5 mM KCl, 1.2 mM Mg 2 SO 4 , 8 mM glucose) containing 1% (w/v) n-octyl-b-D-glucoside. Briefly, 5 Â 10 6 cells were added in 100 ml mixture containing ZnSO 4 (10 mM) and FAPGG (1 mM). After incubating for 30 min at 371C, the reaction was stopped by adding 900 ml of distilled water and hydrolysis of FAPGG by ACE was quantified by recording the decrease of absorbance at 340 nm in a Ultrospec 3000 spectrophotometer (Pharmacia Biotech, Orsay, France). Specificity of substrate hydrolysis was confirmed by inhibition of ACE activity by captopril (100 mM) and enalaprilat (10 mM), specific ACE inhibitors. Protein concentrations were determined according to Bradford's assay.
RNA isolation, cDNA synthesis and PCR RNA extraction from treated cells and cDNA synthesis were conducted as described . The cDNAs for human b 2 -microglobulin, ACE and TACE were amplified by PCR, and primers were designed according to published sequences (Costerousse et al., 1993; Satoh et al., 2000; Sanceau et al., 2002) . b 2 -Microglobulin cDNA (165 bp) was amplified using the sense primer 5 0 -CAT CCA GCG TAC TCC AAA GA-3 0 and the antisense primer 5 0 -GAC AAG TCT GAA TGC TCC AC-3 0 . ACE cDNA (673 bp) was amplified using the sense primer 5 0 -GAT GTG GCC ATC ACA TTC GTC AGA-3 0 and the antisense primer 5 0 -CAC TGC ACC AGT GTG ACA TCT ACC-3 0 . TACE cDNA (190 bp) was amplified using the sense primer 5 0 -ACC TGA AGA GCT TGT TCA TCG AG-3 0 and the antisense primer 5 0 -CCA TGA AGT GTT CCG ATA GAT GTC-3 0 . The PCR products were visualized by electrophoresis in 2% agarose gel containing 0.2 mg/ml ethidium bromide. The NIH Image 1.63 software was used for the analysis of the bands after acquisition in an Appligen densitometer (Oncor, Illkirch, France).
ELISA analysis
The culture supernatants from cells (1 Â 10 6 cells/ml) cultured for 3 days in the absence or presence of IFNg (1000 U/ml) were tested for ACE and TACE contents using commercial ELISA kits (R&D, Abingdon, UK). Controls included FCS-supplemented RPMI 1640 medium incubated under the same conditions. Detection level for ACE and TACE was 10 pg/ml.
Immunofluorescence labeling of TACE by fluorescent microscopy Cells were washed twice with cold phosphate buffer saline (PBS), then fixed in PBS containing 3% paraformaldehyde for 15 min at room temperature. For permeabilization, cells were incubated in ice-cold methanol for 15 min and then washed twice with PBS. After 20 min of blocking in PBS containing 1% bovine serum albumin (BSA) at room temperature and subsequent PBS washes, cells were then incubated in the same buffer with unlabeled anti-TACE (50 mg/ml) or its isotype mIgG1 (50 mg/ml) for 45 min at 371C. Cells were washed twice with PBS, followed by an incubation for 30 min at 371C with a F(ab 0 )2 fragment anti-mouse fluorescein isothiocyanateconjugated Ig (5 mg/ml) in PBS/BSA. Preparations were then washed twice with PBS. Cells were centrifuged (5 min, 300 r.p.m.) on slides that were then mounted in Vectashield. Labeled samples were further analysed by microscopy on a microscope equipped for epifluorescence (BX60, Olympus, Tokyo, Japan) with a video camera, using an Olympus X 63 oil-immersion objective.
Western blot analysis
Following cell stimulation with IFNg (1000 U/ml) for 16 h, total cell extracts were prepared, separated on 12% polyacrylamide-sodium dodecyl sulphate gels, transferred to nitrocellulose and blotted as described (Sanceau et al., 2002) . Membranes were hybridized with Abs for IRF1 and actin as described (Sanceau et al., 2002) using chemiluminescence technique developed by Santa Cruz. Immunoreactive protein bands were detected by autoradiography on Hyperfilms (Kodak) and the bands were acquired with an Appligen densitometer.
Statistical analysis
Values are represented as means7s.e.m. of n separate experiments. Statistical analysis was performed using the Student's t-test and the analysis of variance test for significance.
